Sildenafil cream for female sexual arousal disorder available to prescribe in select states
In male rabbits, diabetes produces penile cavernous trabecular smooth muscle fibrosis based on the degree of hyperglycemia (16).
Are there other uses for this medicine?
The doctor can advise on the suitabilty of the products, and they may recommend medications such as Addyi and Vyleesi. Vyleesi (bremelanotide) and Addyi (flibanserin) can help treat female sexual interest/arousal disorder (FSIAD) in premenopausal people. The FDA has not approved Viagra for use in females. The FDA also advises against taking over-the-counter supplements that are marketed to boost libido. Medication may not treat all causes of low sexual desire.
Inclusion Criteria
A person can contact a doctor for advice on suitable medications and other ways to help improve their libido. During menopause and perimenopause, many women experienced diminished or less intense orgasms. Topical sildenafil increases blood flow to wherever you apply it (in this case, sildenafil film tablet your clitoris or labia), and increased blood flow leads to increased sensation. Sildenafil: Increases blood flow, stimulates natural lubrication, and heightens physical sensations leading to a stronger, more fulfilling orgasm. In a 2002 study, sildenafil was found to be effective in enhancing vaginal engorgement in healthy premenopausal women.
Erectile dysfunction
We've found that it works well in perimenopausal and menopausal women as well! Pentoxifylline: Influences changes in blood flow and improves blood flow to genital tissue. Ergoloid Mesylate: Stimulates neurotransmitters associated with sexual pleasure and increases blood flow. aDepartment of Microbiological Science and Gynaecological Science, School of Medicine, University of Catania, Catania, Italy bResearch Group for Sexology, School of Medicine, University of Catania, Catania, Italy Received June 18, 2005; Revised October 5, 2005; Accepted October 5, 2005; Published online March 30, 2006 DOI: 10.1016/j.fertnstert.2005.10.043 External LinkAlso available on ScienceDirect External Link Copyright: © 2006 American Society for Reproductive Medicine. There is evidence that women with sexual dysfunction will commonly have physiologic abnormalities such as vasculogenic dysfunction (1) or diabetes (2) that contribute to their overall sexual health problems. Several pharmacological agents, some with central-acting mechanisms and some with locally acting vascular effects, are therapeutically useful in the treatment of ED (17). Selective phosphodiesterase type 5 (PDE5) inhibitors, taken orally, are effective for men with ED and concomitant type 1 diabetes (18–21).
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 100mg | 20 Pills | 45.58€ 43.41€ | |
| Viagra Generic | 150mg | 360 + 10 Pills | 423.48€ 403.31€ | |
| Viagra Generic | 150mg | 10 Pills | 36.73€ 34.98€ | |
| Viagra Generic | 200mg | 20 Pills | 61.69€ 58.75€ | |
| Viagra Generic | 25mg | 180 + 6 Pills | 154.93€ 147.55€ | |
| Viagra Generic | 150mg | 120 + 8 Pills | 177.58€ 169.12€ | |
| Kamagra Soft Tabs | 100mg | 20 Pills | 79.79€ 75.99€ | |
| Kamagra Soft Tabs | 100mg | 84 + 4 Pills | 233.05€ 221.95€ | |
| Viagra Generic | 100mg | 30 + 4 Pills | 60.91€ 58.01€ | |
| Kamagra | 100mg | 180 + 6 Pills | 436.79€ 415.99€ | |
| Viagra Generic | 25mg | 120 + 6 Pills | 125.56€ 119.58€ | |
| Viagra Generic | 25mg | 30 + 4 Pills | 47.97€ 45.69€ | |
| Viagra Generic | 200mg | 90 + 6 Pills | 170.79€ 162.66€ | |
| Viagra Generic | 25mg | 10 Pills | 25.19€ 23.99€ | |
| Viagra Generic | 150mg | 180 + 10 Pills | 236.46€ 225.20€ | |
| Viagra Generic | 200mg | 180 + 10 Pills | 277.56€ 264.34€ | |
| Viagra Generic | 50mg | 30 + 4 Pills | 54.26€ 51.68€ |
Previous studies suggested that sildenafil, which acts by inhibiting cyclic GMP-specific PDE5, may improve the sexual health of women affected by sexual difficulties such as arousal disorders and may indirectly improve other aspects of sexual life (22, 23).
Is Viagra an Option for Female Sexual Dysfunction?
The sexual function of diabetic women has received little attention in clinical research, even though diabetes recently has been shown to increase the risk of female sexual dysfunction (3, 4). In diabetic rats, diabetes induces vaginal tissue fibrosis and adverse effects on the hemodynamic mechanism of clitoral engorgement (5). Diabetic women could have decreased sexual desire depending on the indirect effect of diabetes resulting from the increased prevalence of depression (6). On the other hand, changes in sexual genital pathways such as diminished clitoral sensation, vaginal dryness, vaginal discomfort, orgasmic dysfunction, and dyspareunia might be the mechanisms that involve damage to the vascular and autonomic nervous system (4, 7) and cause alterations in the nitric oxide (NO) production and its efficacy (8). The most commonly reported sexual problem in women with diabetes is sexual arousal disorder (SAD) (4, 9).
Interactions with other medications
Physiologically, in the sexual arousal phase, sexual excitement is accompanied by pelvic vasocongestion and swelling of the external genitalia, including clitoral and vaginal engorgement; clitoral engorgement appears to be mainly a hemodynamic phenomenon characterized by smooth muscle relaxation (10–12). Diabetes is usually associated with atherosclerosis and microangiopathy (13), and diabetic subjects may have chronic cavernous arterial insufficiency. This could sildenafil pick up also be the case of male erectile dysfunction (ED). Men with diabetes have an approximately threefold higher risk for ED than men without diabetes (14). The pathophysiology of ED in diabetic men is known to be related to vascular and neuronal origin (15). Because subjects affected by chronic illness such as diabetes may suffer from a sexual dysfunction due to neurovascular alterations, research needs to be carried out to find drugs that are effective in treating the pathological effects to improve the quality of sexual life.
See also:
Vyleesi targets melanocortin receptors, which are linked to sexual function. The drug modulates the brain pathways involved in sexual response. After 3 days of taking the medication, there is a steady level of the drug in the body. However, some people do not metabolize CYP2C19, an enzyme protein, effectively, and this can cause levels of the drug to build up, resulting in side effects. Vyleesi lasts around 2.7 hours, and the average time it takes to clear the body is 6.5 hours.
What special precautions should I follow?
The drug may slow how fast the body can process other medication. Vyleesi and Addyi treat FSIAD in premenopausal people. No research has tested the drug in people during or after menopause. The medications may be beneficial for premenopausal people who: Factors that are lined with a reduced sex drive in females include: certain health conditions, such as diabetes and heart disease The FDA-approved drugs for FSIAD can have the following side effects. The side effects of Addyi can include: those who have consumed alcohol in the last 2 hours The drug can cause severe low blood pressure and fainting in people who take it with alcohol or who have liver conditions.
Osphenia (Ospemifene)
irritation or a rash at the injection site darkening of the skin, resulting in dark spots called hyperpigmentation on the gums, face and breasts Vyleesi may reduce the efficiency of oral medications due to slower emptying of the gastric system. It can also make drugs containing naltrexone to treat alcohol and opioid addiction less effective, so anyone taking a drug that contains naltrexone should avoid Vyleesi. Like other drugs, Vyleesi and Addyi can cause allergic reactions. Seek immediate medical help if symptoms of an allergic reaction or anaphylaxis occur. A person should speak with a doctor before taking any supplements to boost libido. This double-blind crossover placebo-controlled study was designed to determine whether sildenafil, taken orally, was able to improve sexual genital arousal in type 1 diabetic women with SAD using subjective and objective instruments to measure the efficacy of the drug.
- Female sexual dysfunction affects millions worldwide, prompting research into treatments.
- Sildenafil is part of a broader conversation about women’s sexual health innovations.
- The role of sildenafil in improving orgasm quality is still being studied.
- It is essential to distinguish between clinical trial results and off-label use.
- Some women experience mood improvement alongside physical effects with sildenafil.
- Education about both benefits and risks is crucial for women considering sildenafil.
This was an independent study performed at the Research Group for Sexology of the Department of Microbiological and Gynaecological Science, School of Medicine, University of Catania, Catania, Italy. The Institutional Review Board of the department approved the study.
- The market for female sexual enhancement drugs is growing, including sildenafil research.
- Women should be aware of potential drug interactions when using sildenafil.
- Female sexual health involves multiple factors, not just blood flow.
- Sildenafil may not be effective for all women due to physiological differences.
- Regular follow-up with healthcare providers can optimize treatment and safety.
- Lifestyle factors such as stress and hormonal balance influence female libido.
Thus 36 consecutive premenopausal women aged 27–43 years, with a mean age (±SD) of 34 (±3.6) and a body mass index of 25.3 ± 3.8, affected by type 1 diabetes that was being treated with insulin therapy, and visiting the outpatient Sexology Service for SAD were invited to participate.
- Some women seek sildenafil for increasing genital blood flow and sensation.
- The placebo effect can influence perceived benefits in women using sildenafil.
- Women with cardiovascular risk should avoid sildenafil unless approved by a doctor.
- Topical or alternative therapies might be considered alongside or instead of sildenafil.
- Scientific consensus on sildenafil’s safety for women remains under development.
- Proper dosing and medical oversight are key to minimizing risks.
All the subjects gave their written informed consent before entering the study, which was conducted in accordance with the Helsinki Declaration.
| Use | Description | Typical Dosage | Notes |
|---|---|---|---|
| Female Sexual Arousal Disorder | Helps increase blood flow to enhance arousal | 25-50 mg | Prescribed by a doctor |
| Pulmonary Hypertension | Off-label use for specific pulmonary issues | 20 mg | Under medical supervision |
| Enhancing Clitoral Blood Flow | Used to improve clitoral responsiveness | Variable | Not FDA-approved for women |
| Treatment of Female Dyspareunia | Aims to reduce pain during intercourse | Experimental | Limited clinical trials |
However, the subjects could terminate participation at any time. The study was not advertised, and no remuneration was offered. The sample consisted of volunteers who had had a stable, satisfying heterosexual relationship for at least 6 month and subjectively normal sexual desire toward their partners (see Instruments section). Women were excluded from the study if they had a history of hypertension, coronary artery disease, or thromboembolic disorder; impaired hepatic and renal function and neoplasia; were taking hormone therapy or oral contraceptives; had a history of smoking and alcohol abuse; did not have a sexual partner; were affected by situational sexual dysfunction with their partner; or had a partner with sexual dysfunction.
| Brand Name | Formulation | Dosage Options | Notes |
|---|---|---|---|
| Viagra Women | Oral tablet | 25 mg, 50 mg | Off-label use, not approved by FDA |
| Female Arousal Gel | Topical gel | N/A | Claimed to enhance blood flow |
| Sildenafil Citrate | Generic oral tablet | 25-100 mg | Widely used off-label in women |
| Custom Compounded | Customized formulations | Variable | Prescribed by special clinics |
All patients admitted to the screening phase had regular menstrual cycles (mean cycle length 26.7 ± 4.2 days), with ovulation. To confirm the ovulatory cycle, ultrasound was performed on days 10, 12, and 15 of the cycle and serum P concentrations were measured at days 21 and 25 of the cycle.
Other Treatments for Low Libido
The FDA has approved two drugs to address FSIAD: Vyleesi (bremelanotide) and Addyi (flibanserin). Addyi was the first drug approved to treat FSIAD. Addyi is designed for premenopausal people, and is available as a pill. A person takes this drug daily before bed, even if they do not intend to have sex that day. It can take no more than 8 weeks to see an increase in sexual desire, though some people experience the effects much sooner.
Statistical Analysis
The FDA states that Vyleesi medication can treat FSIAD in premenopausal females. A person injects it into their thigh or stomach at least 45 minutes before having sex. The effects can last for up to 24 hours. People should not use the drug more than eight times per month. The table below compares Vyleesi and Addyi: Viagra is not FDA approved for use in females.
A Note on Gender and Sex Terminology
To understand why, it can help to understand what Viagra was designed to do in the male body. Usually, after sexual stimulation in a male, there is a release of nitric oxide, which increases levels of a regulatory agent in cells called cyclic guanosine monophosphate (cGMP). This increase in cGMP causes smooth muscle relaxation, and sildenafil citrate 150 mg red pill it leads to increased blood flow to the penis, resulting in an erection. In males, an erection goes down when an enzyme called phosphodiesterase type 5 (PDE-5) breaks down. Anyone who would like to try Viagra should ask a medical professional, who may prescribe the drug off-label. Menstrual cycle was defined as ovulatory when the serum P was >18 IU/mL. The P level was measured using commercially available enzyme-linked immunoassorbent assay (ELISA) kits (Elecsys System 2010; Roche, Monza, Italy).
- 10 OVERDOSAGE
- What is Hiforce 200mg Tablet(Sildenafil Citrate 200mg)?
- Sildenafil Prices, Coupons, Copay Cards & Patient Assistance
- Cialis 10mg for Benign Prostatic Hyperplasia (BPH) Treatment
- Super P Force Discount Offers and Deals
- 6 coisas que você precisa saber sobre o suposto "Viagra Feminino"
- Pfizer va lancer en France un générique du Viagra
Site Operator
Fabienne Heyne
[email protected]
Corporate Design
Silvio Ketterer Visuelle Gestaltung
www.silvioketterer.ch
Website Programming
RHOdesign
www.rhodesign.ch
Photography
Angelika Annen
www.angelikaannen.ch